Oramed Pharmaceuticals Inc. (ORMP) bonds
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.87−0.03 (-0.77%)
Close on Nov 17, 2026Market cap $160.98MP/E 0.9Yield 6.46%
Debt
Borrowings on the balance sheet, Jun 30, 2026
Oramed Pharmaceuticals reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Oramed Pharmaceuticals's 10-Q for the period ended May 13, 2026
| Issue | Coupon | Matures | Amount issued |
|---|---|---|---|
| Junior Participation Interest In83 Wythe Loan | 8.00% | Oct 15, 2028 | – |
| Convertible Notes SPA Convertible | – | – | $25.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?